Higher thyroid stimulating hormone leads to cardiovascular disease and an unfavorable lipid profile: EVidence from multi-cohort Mendelian randomization and metabolomic profiling. (August 2021) - Van Vliet, N.A.; Bos, M.M.; Thesing, C.S.; Chaker, L.; Pietzner, M.; Houtman, E.; Neville, M.J.; Li-Gao, R.; Trompet, S.; Mustafa, R.; Ahmadizar, F.; Beekman, M.; et al.